[{"author":"PresciencePoint","content":"MiMedx Shareholders Overwhelmingly Support Election of All Three of MiMedx's Highly Qualified Director Nominees\u2026 https:\/\/t.co\/KA7p9mfZX2","pubdate":"20190617140602","NumFavorite":7,"NumShare":6,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"We want to thank our fellow $MDXG shareholders for their overwhelming support in nominating our highly-qualified Bo\u2026 https:\/\/t.co\/FJMQjz5GLO","pubdate":"20190617154015","NumFavorite":5,"NumShare":4,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"Concerns raised by the @WSJ over $MDXG's Amniofix injectable products should be contextualized. Amniofix represents\u2026 https:\/\/t.co\/U1skdRcpVi","pubdate":"20190617154016","NumFavorite":5,"NumShare":1,"CrawlerDate":"20200720"},{"author":"PresciencePoint","content":"Despite a &gt;2x increase in price since our Initiation Report, we believe $MDXG is still significantly undervalued.\u2026 https:\/\/t.co\/pjNYVsFysp","pubdate":"20190617154016","NumFavorite":4,"NumShare":1,"CrawlerDate":"20200720"}]